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Abstract Myelin is a multilamellar membrane structure
primarily composed of lipids and myelin proteins essential
for proper neuronal function. Since myelin is a target structure
involved in many pathophysiological conditions such as
metabolic, viral, and autoimmune diseases and genetic myelin
disorders, a reliable myelin detection technique is required
that is equally suitable for light- and electron-microscopic
analysis. Here, we report that single myelinated fibers are
specifically stained by the gold phosphate complex, Black
gold, which stains myelin in the brain, spinal cord, and
peripheral nerve fibers in a reliable manner. Electron-
microscopic and morphometric analyses have revealed that
gold particles are equally distributed in the inner, compact,
and outer myelin layers. In contrast to Luxol fast blue, the gold
dye stains proteinase-sensitive myelin structures, indicating its
selective labeling of myelin-specific proteins. Aiming at
defining the target of gold staining, we performed staining in
several mouse myelin mutants. Gold complex distribution and
myelin staining in MBP−/−/shiverer mouse mutants was
comparable with that seen in wild-type mice but revealed a
more clustered Black gold distribution. This gold staining
method thus provides a sensitive and specific high-resolution
marker for both central and peripheral myelin sheaths; it also
allows the quantitative analysis of myelinated fibers at the
light- and electron-microscopic level suitable for investiga-
tions of myelin and axonal disorders.
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Introduction
Myelin in the central nervous system (CNS) is an essential
structure for the proper functioning of neuronal signal
transmission. This specialized structure surrounding axons
exhibits a multilamellar, spirally wrapped extension of the
plasma membranes originating from oligodendrocytes in
the CNS and of Schwann cells in the peripheral nervous
system (PNS; Morell et al. 1994). Serving as an axonal
insulator, myelin sheaths allow saltatory impulse conduc-
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tion and thereby reduce energy and space expenditure by
the nerve cell (Henderson et al. 2001). However, myelin
also exhibits growth-inhibitory properties for axons that
have been shown to contribute to lack of functional
recovery following neurotrauma (for a review, see Yiu
and He 2006). The clinical significance of myelin is
reflected by its disturbance in CNS pathologies such as
immune-mediated, virus-mediated, metabolic, and inherited
demyelinating diseases (Lazzarini 2004).
Over 70% of the dry weight of myelin consists of lipids
(Cammer and Norton 1976), and the remainder comprises
myelin-specific proteins such as myelin-associated glyco-
protein (MAG), oligodendrocyte-myelin glycoprotein
(Omgp), myelin basic protein (MBP), proteolipid protein
(PLP), 2',3'-cyclic nucleotide phosphodiesterase, protein P0,
PMP-22, and reticulon-4 (Rtn-4)/Nogo (Campagnoni and
Macklin 1988; Smith 1992; Taylor et al. 2004; Dumont
et al. 2007). A common approach for the detection of
myelin is antibody-based immunocytochemistry staining
for surrogate marker proteins of oligodendrocytes and
myelin-specific proteins. However, the disadvantage of this
approach is the requirement for specific antibodies suitable
for immunostaining, and hence, the dynamic expression of
the antigen of interest during the course of development
and injury impacts staining results. A conceptually different
approach aims to detect the specific lipid composition of
myelin. Thus, many existing methods for myelin staining
are based upon a high affinity to myelin lipids and non-
soluble phospholipids: diamine silver (Gallyas 1979),
Sudan black (Meier 1976), potassium dichromate hematox-
ylin stain (Weigert 1884), Oil red O, or Luxol fast blue
(LFB; Kluver and Barrera 1953). However, when single
fiber resolution is required, these staining approaches do
not meet the necessary contrast and resolution quality. For
these aspects, silver staining techniques first developed by
Gallyas (1979) are utilized and remain, with modifications,
the standard (Pistorio et al. 2006). Other than its applica-
bility for postembedding procedures, the disadvantages of
this technique are the unpredictability of the signal-to-noise
ratio (time of development and background), the significant
time input, and the complex staining procedure.
By comparison, gold-based staining techniques represent
an alternative that meets the criteria of high resolution and
reproducibility (Meier et al. 2003, 2004; Schmued and Slikker
1999). In this study, we have performed a morphometric and
ultrastructural analysis of myelin in the PNS and CNS by
using an improved gold-based staining method (product
launched as Black gold; BG) and have investigated the target
of gold-particle staining. We show that BG stains all myelin
layers with the same affinity (inner, compact, and outer
myelin layers), independently of the axonal diameter. In
addition, the structures showing affinity for BG are mostly
proteinase-sensitive, indicating that the gold complex stains
myelin-specific proteins or protein-lipid complexes. To
unravel the molecular target of gold affinity further, we have
tested various mouse strains deficient for myelin proteins
such as MAG, NogoA (Rtn-4) and shiverer/MBP.
Our data reveal that BG stains myelin sheaths of mature
axons in the adult brain and myelin in peripheral nerves.
Furthermore, the gold stain detects subtle alterations in myelin
in genetically modified animals such as in shiverer mice. Thus,
we provide here a simple method for staining myelin at high
resolution and contrast at the single fiber level suitable for the
detection of myelin under neuropathological conditions.
Materials and methods
Animals and tissue preparation
Wistar male rats (200–300 g body weight) and adult wild-
type and mutant mice (Shiverer/MBP−/−, MAG−/−; NogoA−/−
(Rtn-4), MAG/NogoA double mutants) housed under stan-
dard laboratory conditions. Animals were deeply anesthetized
with an overdose of the anesthetic mixture of Ketanest
(Gödecke/Park-Davis, Germany), Rompun (Bayer, Ger-
many), and Ventranquil (Sanofi-Ceva, Germany) and trans-
cardially perfused with 200 ml saline followed by 250 ml 4%
paraformaldehyde (PFA) containing 0.2%–2% glutaraldehyde
dissolved in 0.1 M phosphate buffer (PB) for gold phosphate
(BG) staining. The tissue was postfixed in 20% sucrose in 4%
PFA solution for 2 days, shock-frozen in the gaseous phase of
liquid nitrogen, and stored at −80°C. Animals used for LFB
staining were decapitated, after which the brains, sciatic
nerves, spinal cord, kidney, and liver were immediately
removed, frozen, and stored at −80°C. All sections were cut
on a cryostat microtome (Leica) at a thickness of 20–50 µm.
Myelin staining technique with gold particles
A 0.2% working solution of gold chloride (AuCl4; Merck,
Darmstadt, Germany) or gold phosphate (BG granulate;
Histo-Chem, Jefferson, USA) was prepared in 0.9% NaCl,
briefly heated at 60°C, and, for full equilibration, stored in
the dark overnight at room temperature. Cryocut sections
were washed with 0.1 M PB and subsequently stained with
0.2% gold phosphate solution, warmed to 45–60°C, for 15
to 40 min according to Jabonero (1953). To intensify the
staining, the sections were incubated in 0.2% potassium
tetrachloroaureate (Sigma-Aldrich Chemie, Germany) dis-
solved in 0.9 % NaCl for 15 min. For fixation, sections
were incubated for 3 min in 2% sodium chlorate (Merck)
dissolved in 0.9% NaCl. This procedure proved suitable for
the myelin staining of free-floating sections, giving the
same results as on sections attached to slides, and allowed
counterstaining to be performed. Sections were stained for
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1.5 min in a 0.1% acetic acid solution of 0.4% malachite
green (Sigma-Aldrich Chemie), rinsed in distilled water for
1 min, and differentiated in 70% ethanol to remove
background staining. In between each step, the sections
were carefully rinsed three times in 0.1 M PB for 5 min.
The free-floating sections were mounted on SuperFrostPlus
slides (Menzel-Glaeser, Berlin, Germany), air-dried, dehy-
drated in graded ethanol, cleared in xylene, and cover-
slipped with Entellan (Merck).
LFB staining
The tissue was postfixed in −20°C cold methanol for 2 min
and then transferred to an ethanol/acetic acid mixture (96%/
4%) for 5 min. Sections were stained in a 0.1% LFB
solution dissolved in the same ethanol/acetic acid mixture
at 60°C for 3 h, rinsed in 96% ethanol, postfixed in 0.05%
Li2CO3 for 1 min, washed in 70% ethanol for a few
seconds, counterstained with Harris’ hematoxylin for 1–
2 min, dehydrated in graded ethanol, and coverslipped with
Entellan (Merck).
Protein digestion
Sections were incubated with 50 µg/ml proteinase K
(Boehringer, Germany) dissolved in 0.01 M TRIS (pH
8.0) and 0.1 % SDS at 37°C for 40 min or with 0.25 %
trypsin in a dilution buffer containing 0.04% KCl, 0.22%
NaHCO3, 0.68% NaCl, 0.1% glucose and then stained with
BG or LFB as discribed above.
Electron microscopy
BG sections were osmicated (1% OsO4 in 6.84% sucrose/
PB for 5 min), dehydrated in graded ethanol, and flat-
embedded in Epon between silane-coated slides. Ultrathin
sections were cut on a Reichert Ultratome (Germany),
mounted on single-slot grids coated with Formvar film, and
stained with lead citrate and uranyl acetate. A Zeiss EM
900 electron microscope was used for examination, and
microphotographs were taken with a digital camera (Zeiss,
Jena, Germany).
Quantification of myelinated fibers and axonal diameters
For densimetric measurements of the myelinated fibers, we
used a computerized videodensitometry system (Meta-
Morph, Universal Imaging, Downingtown, Pa., USA). A
visually established pixel intensity threshold was set to
remove the unlabeled portion of the image. Statistical
analysis was performed with the Mann-Whitney U-test
(StatViewII, Abacus, USA). The levels of significance were
set at *P<0.05, **P<0.01, and ***P<0.001.
Results
Myelinated fibers in CNS detected with gold staining
First, we assessed BG staining on brain sections of adult
rats. BG staining specifically appeared as red-brown
coloration in white matter areas at low resolution,
whereas gray matter areas were stained to a lower
extent, in parallel with their myelin content (Fig. 1). The
BG staining suitably reflected the myeloarchitecture of the
CNS, staining the main white matter tracts such as corpus
callosum and anterior commissure (Fig. 1a, b). In addition,
higher magnification revealed single thin gold-positive
fibers in the cortex and olfactory bulb, whereas neuronal
cell bodies remained unstained (Fig. 1b–d). In the cortex,
the majority of stained myelinated axons were vertically
oriented. BG stain uncovered cortical neurites inter-
mingled with horizontally running fibers, which formed
a fine dense network (Fig. 1e, f). Staining of the entorhino-
hippocampal formation visualized both the afferent and
efferent axonal projections, such as the perforant path,
alveus, and the fimbria-fornix system (Figs. 1, 2). Staining
intensity varied in between the various hippocampal sub-
fields reflecting the laminar organization of the fiber
projections, e.g., the strong gold labeling in the stratum
lacunosum-moleculare of the cornu ammonis 1 (CA1) and
stratum radiatum of CA1–CA3 (Fig. 2a). Myelinated fibers
formed a dense network in the neuropil and were often
observed surrounding the neuronal somata of the granule and
pyramidal cells (Fig. 2b). Electron-microscopic analysis
revealed single gold particles distributed along myelin
sheaths (Fig. 2c). Other subcellular structures and organelles,
such as mitochondria, nuclei, or endoplasmic reticulum,
remained unstained (Figs. 2, 3). Subsequent quantitative
analysis revealed that gold particles surrounded mature
axons and were equally distributed in the inner, compact,
and outer layers of the myelin spirals (33±8 particles/5 µm2;
mean±S.D., Mann-Whitney U-test). Gold particles were also
located along myelin sheaths surrounding axons of various
diameters ranging from 120 nm to 260 nm, whereas dendritic
processes were BG-negative.
We subsequently analyzed spinal cord sections stained
with this dye. Gold-positive fibers could be found in all
white matter fiber tracts with prominent staining of
descending fibers (i.e., fasciculus gracilis, cerebrospinal
and anterior spinothalamic tracts; Fig. 3). Myelinated fibers
from the dorsal root entering the gray matter were also
positively stained for BG (Fig. 3b). Ultrastructural analysis
confirmed the nature of gold-positive fibers as being
myelinated (Fig. 3c, d), with gold particles being distributed
irregularly along the myelin sheaths without preference for
the inner, compact, or outer layers of myelin spirals
(Fig. 3c, d).
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Myelinated fibers in PNS detected with gold staining
Since the composition of peripheral myelin differs remark-
ably from that found in the CNS (Uyemura et al. 1995;
Avila et al. 2007), we have addressed the question as to
whether BG is also a suitable dye for myelin detection in
the PNS. We therefore stained the sciatic nerve with BG, by
applying the same procedure and tissue treatment as above.
In the peripheral nerves, the distribution of the gold stain
was comparable with that found in CNS myelin. Gold
particles were clustered around all myelin sheaths (inner,
compact, and outer loops of myelin spirals), whereas the
axonal plasma and the extracellular space were almost free
of any staining (Fig. 4). Within the myelin structure, non-
Fig. 1 Distribution of Black
gold (BG)-positive fibers in the
adult CNS. a Overview of a
gold-stained coronal brain sec-
tion. Note the intense staining of
fiber tracts such as corpus cal-
losum (cc), anterior commissure
(ac), and internal and external
capsule. b Higher magnifican-
tion of the corpus callosum (cc).
c The lateral olfactory tract (lo)
and anterior commissure (ac)
show BG-positive fibers in red-
brown, whereas the ondulated
primary olfactory cortex (PO) is
BG-negative (CP caudate puta-
men). d Higher magnification of
the olfactory tract shown in c
reveals single myelinated fibers,
although neurons in the olfacto-
ry cortex (counterstained with
malachite green) show no BG
staining (PO primary olfactory
cortex). e BG staining of the
temporal cortex (I–VI layers of
the cortex). Note the intense
labeling of the white matter by
BG. In addition, vertical-
oriented axon profiles are BG-
positive (wm white matter). f
High magnification of e. Bars
1 mm (b), 40 µm (c), 220 µm
(d), 80 µm (e), 150 µm (f)
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compact myelin such as Schmidt-Lanterman incisures and
Schwann cell cytoplasm were almost devoid of BG
particles (Fig. 4). Overall, BG staining in peripheral myelin
revealed almost the same contrast and staining intensity as
that found in CNS myelin structures.
Target of myelin gold-particle staining
To define the molecular target of gold staining, we
performed staining of various organs that do not contain
myelin components, i.e., muscle, kidney, and liver. None of
these tissues showed significant BG staining compared with
samples from CNS or PNS (Fig. 5a, b). We therefore
assumed that BG stains distinct myelin proteins specifically
present in peripheral and central myelin structures. To test
this, we utilized brain sections in which proteins were, at
least in part, diminished by proteinase K and trypsin
digestion. In such sections, BG staining was completely
abolished (Fig. 5c). To control for these results, we used
LFB, a dye with high affinity for non-soluble phospholipids
Fig. 2 Light and ultrastructural
distribution of BG particles in
the adult hippocampus. a Over-
view of gold-stained adult hip-
pocampus with adjacent
entorhinal cortex is shown in
(arrows perforant path, hi hilus,
gcl granule cell layer, CA cornu
ammonis, EC entorhinal cortex,
pcl pyramidal cell layer, ml
molecular layer, slm stratum
lacunosum moleculare). b BG
labeling in the dentate gyrus. c
BG labeling in the hilus. d BG
labeling in the CA3 region. e
Ultrastructural analysis of the
stratum lacunosum moleculare
reveals BG deposits around ma-
ture axons in the inner, compact,
and outer layers of myelin.
Mitochondria (stars), axoplasma
(ax), and nuclei are devoid of
BG particles. Bars 700 µm (a),
20 µm (b–d), 3 µm (e)
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(Kluver and Barrera 1953). As expected, this common
myelin marker was unaffected by proteinase pretreatment
(Fig. 5d). These data demonstrate that BG stains proteins or
protein complexes specifically present in peripheral and
central myelin.
These data prompted us to study the gold staining of
brain sections from mice mutant for myelin proteins. Thus,
in order to define further the molecular target of gold
affinity present in myelin, we investigated sections from
homozygous shiverer mouse mutants that lack one major
myelin protein component, viz., MBP (Dupouey et al.
1979; Kirschner and Ganser 1980). In shiverer/MBP-
deficient mice, BG staining was still detectable with the
same intensity in white matter areas (Fig. 6). However, in
contrast to the regular axon-like staining pattern of the
white matter of the spinal cord from wild-type mice, we
observed irregular, discontinous, and more concentrated
staining and a more clustered distribution of BG stain in
shiverer mice (Fig. 6). This could reflect the light-
microscopic correlate of reduced myelin lamellae sheaths
and the membranous debris as found at the ultrastructural
level in shiverer animals (Bird et al. 1978; Privat et al.
1979; Kirschner and Ganser 1980; Rosenbluth 1980).
However, since BG stain still remained in MBP-deficient
mice, myelin proteins other than MBP are probably the
high-affinity targets of gold particles.
Discussion
In this study, we have investigated, with an improved
gold staining procedure, regional distinctions in myelin-
ated fiber distribution in the PNS and CNS and in
shiverer mutant mice. We have been able to show that
gold dye is suitable for specifically and selectively
staining myelin structures in the CNS and PNS with
high resolution at the level of single fibers, facilitating
axonal analysis at the light and ultrastructural levels.
Studies of myelin in the brain by using histochemical
techniques have to be interpreted with some caution. Low
signal-to-noise ratio, intensity, contrast, and considerable
variability in staining and exposure time and the unknown
molecular substrate that is being stained are some of the
possible pitfalls and limitations. In addition, many histo-
chemical techniques do not reliably distinguish between
normal and pathological myelin structures. In addition,
Fig. 3 Light and ultrastructural
distribution of gold particles in
the spinal cord. a, b Longitudi-
nal and transversal sections, re-
spectively, of the spinal cord at
the thoracical level stained with
BG. BG-positive fibers are
found in all white matter areas
of the spinal cord (d dorsal
columns, il intermediate layer, v
ventral columns). c, d Ultra-
structural analysis of the spinal
cord reveals BG particles
(arrows) distributed over the
myelin sheaths (ax axoplasma).
d BG-positive fibers entering
the gray matter arise from the
dorsal roots (top dorsal columns
of the spinal cord, stars mito-
chondria). Bars 500 μm (a, b),
4 μm (d; applies also to c,
magnification ×30,000)
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single fiber resolution is not achieved by some myelin
staining procedures such as LFB, and therefore these
techniques are insensitive for the assessment of dynamic
and subtle axonal pathologies. Here, we have performed
sets of experiments with the modified aurohalophosphate
BG. Ultrastructural analysis has revealed that the gold
complex stains inner, compact, and outer myelin layers with
the same affinity, whereas dendritic processes do not stain
for gold particles. Furthermore, BG stains all layers of
myelin sheaths, independently of axonal diameter, in
agreement with our previous studies on hippocampal
development (Meier et al. 2003, 2004). In addition, this
gold staining method is also applicable to myelin staining
in the PNS. Here, we have found that gold grains are
centered around all myelin sheaths with same preference as
that seen in CNS myelin samples, suggesting that the
components with the same affinity for gold particles must
be present in both CNS myelin and PNS myelin.
These results have prompted us to test which compo-
nents are being stained by gold particles. Pretreatment of
brain sections with trypsin or proteinase K prevents BG
staining. Conversely, the staining pattern of the phospho-
lipid specific dye LFB is not affected by these treatments.
These findings are not surprising, since the target to which
LFB binds with high affinity are non-soluble phospholi-
pids, which are resistant to this treatment (Kluver and
Barrera 1953). However, our findings also indicate that BG-
positive structures are proteinase-sensitive. These mem-
brane structures may comprise myelin-specific proteins or
specific lipid-protein complexes that are present in myelin
and that are disrupted after protease treatment. In the first
case, these myelin protein components must be located in
all myelin layers, or their distribution overlaps in all myelin
compartments, since gold complex deposits are found
virtually in all myelin layers. This is of relevance since
myelin proteins have various localizations. For instance,
MAGs and NogoA are mostly located in the inner and outer
loop of myelin layers, respectively, and myelin oligoden-
drocyte glycoprotein in the outer loop (Trapp et al. 1989;
Huber et al. 2002). In contrast, MBP, PLP, and P0 are
predominantly found in compact central and peripheral
myelin. We speculate that MBP might be a target structure
recognized by gold particles since it is present in CNS
myelin and PNS myelin, in contrast to CNS myelin proteins
such as Rtn4/NogoA and Omgp. Thus, we have tested
various mouse myelin mutants. Brain samples from
NogoA−/−, MAG−/−, and NogoA−/−/MAG−/− double-
mutant mice show almost no differences compared with
wild-type littermates (data not shown) indicating that either
these two proteins do not have high affinity for gold
particles or do not make up the majority of gold-labeled
myelin proteins, and thus, their genetic lack is below
detection levels. Shiverer mice, which are mutant for the
MBP protein, might be devoid of staining and should serve
as a negative control for target identification of gold
labeling. However, the overall staining pattern is not
altered, although a slight alteration in staining intensity
and a clustered distribution of gold-stained fibers are visible
at the light microscopic level. These changes in BG staining
in shiverer mice might reflect the described altered myelin
membrane lamellae and membrane debris found at the
ultrastructural level (Bird et al. 1978; Privat et al. 1979;
Kirschner and Ganser 1980; Rosenbluth 1980). Central and
peripheral myelin is composed of several proteins such as
PLP (Campagnoni et al. 1976), MAG (Li et al. 1996;
McKerracher et al. 1994; Mukhopadhyay et al. 1994), P0
(Greenfield et al. 1973), Omgp (Wang et al. 2002; Kottis
et al. 2002), chondroitin-sulfate proteoglycans (Dou and
Levine 1994; Niederost et al. 1999), and Rtn-4/NogoA
(Chen et al. 2000; GrandPre et al. 2000; Prinjha et al.
2000), which could all be candidate targets with different
affinity for the gold stain. Since gold particles are
distributed all over the central and peripheral myeloarchi-
tecture, the gold stain probably has high affinity to more
Fig. 4 Distribution of gold staining in the peripheral nervous system.
a Longitudinal section of sciatic nerve stained with BG. Particles of
BG (arrows) are found in myelin sheaths along the nerve fibers but
not in the axoplasma (ax) or extracellular space (arrowhead
cytoplasmic Schwann cell process forming an inner mesaxon). b
Higher magnification of peripheral myelin sheaths. Gold particles are
found in all aspects of the myelin spirals. Magnification: ×30,000
(a), ×40,000 (b)
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then one myelin-specific protein component present both in
CNS and PNS. Future studies will concentrate on the
investigation of gold staining on two major myelin protein
components of the PNS and CNS. Analysis of PLP−/− and
P0−/− mice should help to define whether lack of these
major myelin protein components correlates with an altered
gold-particle distribution and intensity at the quantitative
level. Indeed, a prerequisite for a novel dye becoming a
standard staining method for myelin pathologies would
ideally be knowledge of its target and its intensity
correlation with disease progression. In myelin disorders,
myelin proteins might be mislocated or altered in abun-
dance, or myelin spirals might be disturbed with regard to
their thickness or ultrastructure. We thus need to show that
BG can detect all these features.
Taken together, these data indicate that the method
described here is suitable for the detection of myelin
and myelinated axons in the CNS and PNS. In addition,
the gold stain detects the myelin sheaths of degenerating
and newly emerging axons (Meier et al. 2004). Thus,
this gold staining method allows for a wide range of
applications ranging from developmental to regeneration
studies. In summary, we provide here a staining method
with a reliable general myelin dye that is suitable for
histochemical staining concomitantly at the light and
ultrastructural level.
Fig. 5 Gold particles are highly
specific for myelin and stain
proteinase-sensitive myelin
components. a BG-treated cross
sections of kidney reveal no
staining. b BG-positive bundles
of fibers in the abducens nerve
(arrows single fine myelinated
axons). c Following proteinase
K digestion of a brain section,
almost no fibers are stained for
BG (arrows slight BG-positive
staining). d Positive staining
with Luxol fast blue (LFB) still
appears after proteinase K di-
gestion (arrowheads border of
white matter). LFB staining
appears in dark blue (upper
region) and the gray matter in
light blue (lower region).
Hematoxylin-positive nuclei ap-
pear as dark blue spots. Bars
10 µm (a; applies also to b),
50 µm (d; applies also to c)
Fig. 6 Distribution of gold-
phosphate-positive fibers in the
shiverer mouse (MBP−/−) mu-
tant. Longitudinal sections of
the spinal cord at the thoracical
level of a wildtype (WT) mouse
(a) and a shiverer (SHI) mouse
(b) stained with gold phosphate.
BG-positive fibers are found in
all white matter areas of the
spinal cord (arrows scattered but
concentrated gold staining). Bar
15 µm (applies also to a)
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